Literature DB >> 19646653

PPARs and the orchestration of metabolic fuel selection.

Mary C Sugden1, M Gulrez Zariwala, Mark J Holness.   

Abstract

This contribution describes recent advances in our knowledge of the regulatory interactions between the two major oxidative fuels glucose and lipid. It also addresses how the metabolic abnormalities associated with insulin resistance and ischemic diseases impair the ability of skeletal muscle to switch between the use of alternative metabolic fuels and the ability of adipose tissue to function appropriately in relation to the body's requirements for triglyceride mobilisation or storage, as appropriate to nutritional status. We discuss how targeting PPARs might ameliorate metabolic inflexibility in muscle through altered expression of pyruvate dehydrogenase kinase (PDK) isoforms and impact the functions of the adipocyte in lipid buffering and energy homeostasis. Focus has been placed on the participation of the regulatory pyruvate dehydrogenase kinases, PPAR targets, both in the beneficial and the potentially adverse actions of the PPARs in metabolic control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646653     DOI: 10.1016/j.phrs.2009.03.014

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  22 in total

1.  Regulation of substrate utilization by the mitochondrial pyruvate carrier.

Authors:  Nathaniel M Vacanti; Ajit S Divakaruni; Courtney R Green; Seth J Parker; Robert R Henry; Theodore P Ciaraldi; Anne N Murphy; Christian M Metallo
Journal:  Mol Cell       Date:  2014-10-30       Impact factor: 17.970

2.  Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.

Authors:  Costantinos Giaginis; Ekaterini Politi; Paraskevi Alexandrou; John Sfiniadakis; Gregory Kouraklis; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2012-03-18       Impact factor: 3.201

3.  Signaling events in pathogen-induced macrophage foam cell formation.

Authors:  Yazdani B Shaik-Dasthagirisaheb; Samrawit Mekasha; Xianbao He; Frank C Gibson; Robin R Ingalls
Journal:  Pathog Dis       Date:  2016-07-31       Impact factor: 3.166

4.  Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome.

Authors:  Letizia Giampietro; Antonio Laghezza; Carmen Cerchia; Rosalba Florio; Lucia Recinella; Fabio Capone; Alessandra Ammazzalorso; Isabella Bruno; Barbara De Filippis; Marialuigia Fantacuzzi; Claudio Ferrante; Cristina Maccallini; Paolo Tortorella; Fabio Verginelli; Luigi Brunetti; Alessandro Cama; Rosa Amoroso; Fulvio Loiodice; Antonio Lavecchia
Journal:  ACS Med Chem Lett       Date:  2019-02-25       Impact factor: 4.345

5.  Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.

Authors:  Cynthia Zizola; Peter J Kennel; Hirokazu Akashi; Ruiping Ji; Estibaliz Castillero; Isaac George; Shunichi Homma; P Christian Schulze
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-20       Impact factor: 4.733

6.  Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion.

Authors:  Edgars Liepinsh; Elina Skapare; Janis Kuka; Marina Makrecka; Helena Cirule; Edijs Vavers; Eduards Sevostjanovs; Solveiga Grinberga; Osvalds Pugovics; Maija Dambrova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-26       Impact factor: 3.000

7.  PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease.

Authors:  James P Hardwick; Douglas Osei-Hyiaman; Homer Wiland; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  PPAR Res       Date:  2010-03-16       Impact factor: 4.964

8.  Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity.

Authors:  Takehiko Oka; Yuhei Nishimura; Liqing Zang; Minoru Hirano; Yasuhito Shimada; Zhipeng Wang; Noriko Umemoto; Junya Kuroyanagi; Norihiro Nishimura; Toshio Tanaka
Journal:  BMC Physiol       Date:  2010-10-21

Review 9.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

10.  Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma.

Authors:  Bobby Bhatia; Chad R Potts; Cemile Guldal; SunPhil Choi; Andrey Korshunov; Stefan Pfister; Anna M Kenney; Zaher A Nahlé
Journal:  Acta Neuropathol       Date:  2012-03-11       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.